MaxCyte, Inc. revenue breakdown overview

MaxCyte, Inc. revenue for the last year amounted to 38.63 M USD, the most of which — 22.83 M USD — came from its highest performing source at the moment, Cell Therapy, the year earlier bringing 30.55 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought MaxCyte, Inc. 41.29 M USD, and the year before that — 44.26 M USD.